scispace - formally typeset
Search or ask a question
Author

Paolo Giori

Bio: Paolo Giori is an academic researcher from University of Ferrara. The author has contributed to research in topics: Bicyclic molecule & Pyrazole. The author has an hindex of 11, co-authored 42 publications receiving 272 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: In this article, the structure of the 4-Thiocarbamoyl-5-aminoisoxazole (4,3d) compound was definitively assigned by X-ray analysis.

32 citations

Journal ArticleDOI
TL;DR: Trente 6-trifluoromethylpyrazolo [3,4-d] pyrimidines ont ete synthetisees et testees pour leur activite antifongique in vitro contre dix champignons phytopathogenes de differentes classes taxonomiques as discussed by the authors.
Abstract: Trente 6-trifluoromethylpyrazolo [3,4-d] pyrimidines ont ete synthetisees et testees pour leur activite antifongique in vitro contre dix champignons phytopathogenes de differentes classes taxonomiques. Six de ces composes ont une action remarquable contre Sclerotinia minor, Corticium solani et Phoma betae. On discute des relations structure-activite sur la base de ces resultats et des etudes anterieures

18 citations

Journal ArticleDOI
TL;DR: In this article, a new general and efficient synthesis of imidazo[4,5-c]pyrazoles (5 ) was reported, and the key step of this synthetic procedure is the intramolecular cyclodehydration of 5 -alkylamino-4 -nitrosopyrazoles, which affords the title compounds in good yields.

15 citations

Journal ArticleDOI
TL;DR: Douze 6-trifluoromethylpyrazolo [3,4-d] pyrimidine-4(5H)-thiones ont ete synthetisees as mentioned in this paper.
Abstract: Douze 6-trifluoromethylpyrazolo [3,4-d] pyrimidine-4(5H)-thiones ont ete synthetisees. On les a testees in vitro pour leur activite fongicide contre une serie de champignons phytopathogenes de differentes classes taxonomiques. Les valeurs EC50 (50% d'inhibition de croissance) et MIC (concentration minimale qui inhibe totalement la croissance) de quatre composes sont comparables ou inferieures a celles de fongicides commerciaux de reference qui controlent Sclerotinia minor, Corticium solani et Pythium ultimum

15 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: In this paper, the authors describe the comprehensive results of their investigation of interpenetration in organic hydrogen-bonded 3D arrays from the Cambridge Structural Database (CSDB).
Abstract: Interpenetration in extended three-dimensional (3D) arrays has been investigated by a systematic analysis of the crystallographic structural databases, using an ad hoc version of the program package TOPOS. In this paper we describe the comprehensive results of our investigation of interpenetration in organic hydrogen-bonded 3D arrays from the Cambridge Structural Database. The great interest in the self-assembly of organic molecules into hydrogen-bonded supramolecular arrays has prompted us to investigate these systems at a rather unusual level; that is, beyond the formation of synthons, we have examined the topologies of the resulting networks and looked for their entanglements. Within 3D architectures we have extracted a complete list including 122 different motifs showing the phenomenon of interpenetration (76 unseen by the original authors). These organic networks include species assembled by a single or by different building blocks; they are discussed and classified according to the previously introd...

219 citations

Journal ArticleDOI
TL;DR: In this paper, the synthetic routes to substituted 1,2,3-triazoles, including those containing functional groups, based on cyclisation of various nitrogen compounds published during the last 15 years are described.
Abstract: Data on the synthetic routes to substituted 1,2,3-triazoles, including those containing functional groups, based on cyclisation of various nitrogen compounds published during the last 15 years are described. Examples of using new triazole derivatives in agrochemistry, medicine and engineering are given.

197 citations

Patent
Yuhpyng Liang Chen1
12 Nov 1993
TL;DR: Corticotropin-releasing factor (CRF) antagonists have formula (I), wherein A, R3, R4, and R5 are as defined herein this article.
Abstract: Corticotropin-releasing factor (CRF) antagonists have formula (I), wherein A, R3, R4 and R5 are as defined herein. They are useful in the treatment of illnesses induced or facilitated by CRF, such as inflammatory disorders, and depression and anxiety related disorders.

195 citations